NCT04656288View on ClinicalTrials.gov

A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Healthy
Interventions
DRUG

BI 764198 - Formula A

BI 764198

DRUG

BI 764198 - Formula B

BI 764198

DRUG

BI 764198 - Formula C

BI 764198

DRUG

BI 764198 - Formula D

BI 764198

Trial Locations (1)

2060

SGS Belgium NV Research Unit Stuivenberg, Antwerp

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY